课题基金 / 基金详情

Risk Factors for Psychosis in Chromosome 22q11 Deletion Syndrome

Risk Factors for Psychosis in Chromosome 22q11 Deletion Syndrome
染色体 22q11 缺失综合征精神病的危险因素
批准号:
8045393
负责人:
VANDANA SHASHI
金额:
$31.39万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-04-01 至 2014-03-31
关键词:
22q1122q11 Deletion Syndrome22q11.2AchievementAdolescenceAdultAgeApplications GrantsAreaAttentionBrainCategoriesCerebellumCharacteristicsChildChildhoodChromosomesComplexCorpus CallosumCross-Sectional StudiesDataDevelopmentDevelopmental Delay DisordersDiseaseEarly identificationEarly treatmentElderlyEnrollmentEpidemiologyExhibitsFactor AnalysisFamilyGeneral PopulationGenesGeneticGenetic MarkersGenotypeGrantHaplotypesHereditary DiseaseHeritabilityImpaired cognitionImpairmentIncidenceIndividualInheritedIntelligenceInterventionInvestigationLearning DisabilitiesLinkLongitudinal StudiesMagnetic Resonance ImagingMeasuresMemoryMental disordersModelingMolecular AbnormalityMoodsNatureNeuroanatomyNeurocognitionNeurocognitiveNeurodevelopmental DisorderOutcome MeasureParietal LobeParticipantPathogenesisPatientsPlayPopulation StudyPrincipal InvestigatorProbabilityProspective StudiesPsychiatric DiagnosisPsychotic DisordersRecording of previous eventsRelative (related person)ReportingResearch PersonnelRestRetrospective StudiesRiskRisk FactorsRoleSamplingSchizophreniaSchizotypal Personality DisorderShort-Term MemorySigns and SymptomsSingle Nucleotide PolymorphismStructureSubgroupSymptomsSyndromeTemporal LobeTestingTimeVariantVerbal LearningVulnerable Populationsbasecohortexecutive functionexperiencefollow-upfrontal lobegenetic linkagehigh riskimprovedinnovationmedical complicationmemory processmicrodeletionneurodevelopmentneuropsychologicaloutcome forecastprocessing speedprogramsprophylacticprospectivepsychologicresponsesevere mental illnesstheories

项目摘要

项目成果

VANDANA SHASHI的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Chromosome 22q11.2 Deletion Syndrome (22q11DS) is a common genetic microdeletion syndrome, with neurodevelopmental abnormalities in childhood. A remarkably high-risk of psychoses (25-40%) has been identified in adulthood/late adolescence. The relationship between the early neurodevelopmental abnormalities and psychoses in later life is unclear. The study of the neurodevelopmental and genetic abnormalities in children with 22q11DS would enhance the understanding of the trajectory that leads to schizophrenia in this vulnerable group as well as in the general population, since schizophrenia is thought to be a neurodevelopmental disorder. Our hypotheses are that the subset of 22q11DS children that is most vulnerable to psychosis would have: 1) pronounced and worsening abnormalities of neurocognition 2) pronounced and progressive morphological brain abnormalities of the frontal, temporal and parietal lobes, cerebellum and the corpus callosum 3) hemizygous genotypes within the 22q11.2 region that will be distinct from the rest with 22q11DS. These children would have an increased rate of prodromal symptoms and psychiatric disorders at the end of the study. We propose a longitudinal study of the neuropsychological and neuroanatomical changes, and genotype analysis of the hemizygous 22q11.2 interval in a cohort of 70 nonpsychotic children with 22q11 DS and 70 control participants. The aims are to: 1) Conduct a longitudinal assessment of neurocognition, including sustained attention, executive function and verbal working memory. We will also test for prodromal symptoms and psychiatric disorders. 2) Perform longitudinal brain morphometric analyses on magnetic resonance images (MRI) to quantify the corpus callosum, frontal, temporal, and parietal lobes and the cerebellum 3) Genotype specific single nucleotide polymorphisms (SNPs) in the genetic interval corresponding to the critical deleted area of the 22q11.2 region. An an exploratory aim, we will create haplotypes (linked genotypes) in the 22q11DS patients. These findings will be correlated with one another and will be predictive of the subset that will have elevated rates of prodromal symptoms and psychiatric diagnoses. Lay Summary: We will study the links between learning disabilities, brain structure and hereditary variants in the 22q11.2 region in children with 22q11 DS, a genetic condition with a high risk of schizophrenia, to understand the factors that play a role in this severe mental illness.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
Discordance in Diagnoses and Treatment of Psychiatric Disorders in Children and Adolescents with 22q11.2 Deletion Syndrome.
22q11.2 缺失综合征儿童和青少年精神疾病的诊断和治疗不一致。
DOI: 10.1016/j.ajp.2011.03.002
发表时间: 2011
期刊: Asian journal of psychiatry
影响因子: 9.5
作者: [Young,AndreaS, Shashi,Vandana, Schoch,Kelly, Kwapil,Thomas, Hooper,StephenR]
通讯作者: Hooper,StephenR
Completing the puzzle: The search for pieces in the understanding of psychosis risk in 22q11.2 deletion syndrome.
完成拼图:寻找理解 22q11.2 缺失综合征精神病风险的片段。
DOI: 10.1016/j.schres.2017.07.040
发表时间: 2017
期刊: Schizophrenia research
影响因子: 4.5
作者: [Hooper,StephenR, Shashi,Vandana]
通讯作者: Shashi,Vandana
Feasibility and preliminary efficacy data from a computerized cognitive intervention in children with chromosome 22q11.2 deletion syndrome.
对染色体 22q11.2 缺失综合征儿童进行计算机认知干预的可行性和初步疗效数据。
DOI: 10.1016/j.ridd.2013.05.009
发表时间: 2013
期刊: Research in developmental disabilities
影响因子: 3.1
作者: [Harrell,Waverly, Eack,Shaun, Hooper,StephenR, Keshavan,MatcheriS, Bonner,MelanieS, Schoch,Kelly, Shashi,Vandana]
通讯作者: Shashi,Vandana
DOI: 10.1007/s10897-012-9535-5
发表时间: 2012-12
期刊: JOURNAL OF GENETIC COUNSELING
影响因子: 1.9
作者: [Faux, Dana, Schoch, Kelly, Eubanks, Sonja, Hooper, Stephen R., Shashi, Vandana]
通讯作者: Shashi, Vandana
7
    An integrated and diverse genomic medicine program for undiagnosed diseases
    • 批准号:
      10376398
    • 项目类别:
    • 资助金额:
      $14.99万
    • 财政年份:
      2014
    • 负责人:
      VANDANA SHASHI
    • 依托单位:
    An integrated and diverse genomic medicine program for undiagnosed diseases
    • 批准号:
      10224647
    • 项目类别:
    • 资助金额:
      $110.0万
    • 财政年份:
      2014
    • 负责人:
      VANDANA SHASHI
    • 依托单位:
    An integrated and diverse genomic medicine program for undiagnosed diseases
    • 批准号:
      10869526
    • 项目类别:
    • 资助金额:
      $30.46万
    • 财政年份:
      2014
    • 负责人:
      VANDANA SHASHI
    • 依托单位:
    An integrated and diverse genomic medicine program for undiagnosed diseases
    • 批准号:
      10600346
    • 项目类别:
    • 资助金额:
      $56.61万
    • 财政年份:
      2014
    • 负责人:
      VANDANA SHASHI
    • 依托单位:
    海外基金